BFA
TBPH icon

BlackRock Fund Advisors’s Theravance Biopharma TBPH Stock Holding History

BlackRock Fund Advisors’s Portfolio TBPH Stock Details TBPH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q4 		$70.8M Buy
2,221,302
+388,206
+21% +$12M 0.01% 1447
2016
Q3 		$66.4M Buy
1,833,096
+47,389
+3% +$1.32M 0.01% 1373
2016
Q2 		$40.5M Buy
1,785,707
+218,112
+14% +$4.71M 0.01% 1630
2016
Q1 		$29.5M Sell
1,567,595
-16,307
-1% -$267K 0.01% 1762
2015
Q4 		$26M Sell
1,583,902
-17,538
-1% -$278K 0.01% 1882
2015
Q3 		$17.6M Sell
1,601,440
-108,249
-6% -$1.38M ﹤0.01% 2066
2015
Q2 		$22.3M Buy
1,709,689
+209,612
+14% +$3.25M 0.01% 2046
2015
Q1 		$26M Buy
1,500,077
+299,928
+25% +$5.5M 0.01% 1932
2014
Q4 		$17.9M Buy
1,200,149
+432,587
+56% +$7.54M ﹤0.01% 2129
2014
Q3 		$17.7M Sell
767,562
-50,620
-6% -$1.47M 0.01% 2034
2014
Q2 		$26.1M Buy
+818,182
New +$24.6M 0.01% 1851

Other funds holding TBPH

WIM
Woodford Investment Management London, United Kingdom $310M AUM 17.41% 1-Year Est. Return
BG
Baupost Group Boston, Massachusetts $5.42B AUM 22.93% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
First Manhattan
First Manhattan New York $39.2B AUM 21.04% 1-Year Est. Return
CAM
Cormorant Asset Management Boston, Massachusetts $1.95B AUM 773.9% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $1T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
RSCM
Rock Springs Capital Management Baltimore, Maryland $2.05B AUM 161.37% 1-Year Est. Return

BlackRock Fund Advisors's TBPH Position: Q4 2016 in Review

BlackRock Fund Advisors increased its Theravance Biopharma (TBPH) stake by 21% in Q4 2016, buying an estimated $12M and bringing the position to 2,221,302 shares worth $70.8M. The position accounts for 0.01% of the portfolio, ranked #1447.

BlackRock Fund Advisors first reported a position in TBPH in Q2 2014 and has held it in 11 quarters since. 98 funds tracked by Wall St. Rank hold TBPH as of Q4 2016.

  • BlackRock Fund Advisors held 2,221,302 shares of Theravance Biopharma worth $70.8M as of Q4 2016.
  • BlackRock Fund Advisors bought 388,206 Theravance Biopharma shares in Q4 2016, an estimated $12M.
  • Theravance Biopharma made up 0.01% of BlackRock Fund Advisors's portfolio in Q4 2016, its #1447 holding.
  • BlackRock Fund Advisors first reported a position in Theravance Biopharma in Q2 2014 and has held it in 11 quarters since.
  • 98 funds tracked by Wall St. Rank held Theravance Biopharma as of Q4 2016.

Based on BlackRock Fund Advisors's 13F filing for Q4 2016, filed 10 Feb 2017.